|
|
|
About US
About Frontier
Scientific Employment Opportunities
Management Scientific Background
Conferences Quality Statements
Echelon Biosciences was formed from a project under the Center
for Cell Signaling, a State of Utah Center of Excellence, and was incorporated
under the laws of the state of Utah as Echelon Research Laboratories, Inc. on
October 3, 1997. The company has since changed its name to Echelon Biosciences
Incorporated. The company was organized to further the science of lipid cell
signaling and critical metabolic enzymes, which provide new and viable targets
for the development of potential drugs and diagnostics for cancer, diabetes,
inflammation, infections, and cardiovascular disease.
From 1997 through
2004 Echelon primarily used government grants and product sales revenues to fund
its research efforts. In early 2005 Echelon was purchased by Aeterna Zentaris
(NAS: AEZS) for its MEP antiinfectives, PI 3-Kinase small molecule program and
catalog business.
In late 2007, Echelon was acquired by Frontier
Scientific Inc. Frontier is based in Logan, Utah; specializing in Porphyrin and
related compounds and Photo Dynamic Therapy. The new ownership allows expanded
research and funding for many positive aspects for both Echelon and
Frontier.
|
